These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13810061)

  • 21. Concentration of hyperglycemic factor from urine of schizophrenics.
    MORGAN MS; PILGRIM FJ
    Proc Soc Exp Biol Med; 1952 Jan; 79(1):106-11. PubMed ID: 14892054
    [No Abstract]   [Full Text] [Related]  

  • 22. Relation of aromatic amino acids to excretory pattern of schizophrenics.
    MCGEER PL; MCGEER EG; BOULDING JE
    Science; 1956 Jun; 123(3207):1078-80. PubMed ID: 13324153
    [No Abstract]   [Full Text] [Related]  

  • 23. Indolic compounds in the urine of schizophrenics.
    LEYTON GB
    Br Med J; 1958 Nov; 2(5105):1136-9. PubMed ID: 13584877
    [No Abstract]   [Full Text] [Related]  

  • 24. 6-Sulphatoxyskatole in human urine.
    ACHESON RM; HANDS AR
    Biochim Biophys Acta; 1961 Aug; 51():579-81. PubMed ID: 13859147
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic origin of urinary methylamine in the rat.
    DAVIS EJ; DE ROPP RS
    Nature; 1961 May; 190():636-7. PubMed ID: 13720163
    [No Abstract]   [Full Text] [Related]  

  • 26. Neutral steroid excretion by normal and by schizophrenic men.
    MITTELMAN A; ROMANOFF LP; PINCUS G; HOAGLAND H
    J Clin Endocrinol Metab; 1952 Jul; 12(7):831-40. PubMed ID: 14938420
    [No Abstract]   [Full Text] [Related]  

  • 27. Urinary excretion of indoles in schizophrenia.
    CURZON G
    Confin Neurol; 1958; 18(2-4):211-6. PubMed ID: 13597497
    [No Abstract]   [Full Text] [Related]  

  • 28. Corticoid patterns in urine of schizophrenic patients and treatment with pantothenic acid.
    KOSAKA M
    Folia Psychiatr Neurol Jpn; 1960 Dec; 14():307-15. PubMed ID: 13753299
    [No Abstract]   [Full Text] [Related]  

  • 29. DEARNALEY DP: Some constituents of the urine of normal and schizophrenic individuals. Part II.
    ACHESON RM
    Can J Biochem Physiol; 1960 May; 38():503-15. PubMed ID: 13791635
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on hailucinogenic substances in the body of schizophrenics].
    FISCHER E; FERNANDEZ TA; VAZQUEZ AJ
    Sem Med; 1961 Apr; 118():879-82. PubMed ID: 13699821
    [No Abstract]   [Full Text] [Related]  

  • 31. Modifications of paper and thin layer chromatographic methods to increase sensitivity for detecting n-methylated indoleamines in urine.
    Tanimukai H
    J Chromatogr; 1967 Sep; 30(1):155-63. PubMed ID: 6057433
    [No Abstract]   [Full Text] [Related]  

  • 32. Indoluria in schizophrenia: II. Chromatographic study on 40 schizophrenic and 10 normal subjects.
    FORREST AD
    J Ment Sci; 1959 Jul; 105():685-92. PubMed ID: 13823998
    [No Abstract]   [Full Text] [Related]  

  • 33. Indoluria in schizophrenia: I. Statistical study and investigation of hepatic function.
    FORREST AD
    J Ment Sci; 1959 Jul; 105():674-84. PubMed ID: 13823997
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary aromatic excretion patterns in schizophrenia.
    GOLDENBERG H; FISHMAN V; WHITTIER J; BRINITZER W
    AMA Arch Gen Psychiatry; 1960 Feb; 2():221-30. PubMed ID: 13850628
    [No Abstract]   [Full Text] [Related]  

  • 35. Myelin basic protein-like material in the urine of multiple sclerosis patients: relationships to clinical and neuroimaging changes.
    Whitaker JN
    Mult Scler; 1998 Jun; 4(3):243-6. PubMed ID: 9762682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glial toxicity in urine and multiple sclerosis.
    Malcus-Vocanson C; Giraud P; Micoud F; Janin V; Charles MH; Broussolle E; Chazot G; Mandrand B; Perron H
    Mult Scler; 2001 Dec; 7(6):383-8. PubMed ID: 11795460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identity and significance of some pink spots in schizophrenia and other conditions.
    Perry TL; Hansen S; MacDougall L
    Nature; 1967 Apr; 214(5087):484-5. PubMed ID: 6040612
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychotogenic N,N-Dimethylated indole amines and behavior in schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Recent Adv Biol Psychiatry; 1968; 10():6-15. PubMed ID: 4873523
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"].
    Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A
    Encephale; 1969; 58(4):360-76. PubMed ID: 5378191
    [No Abstract]   [Full Text] [Related]  

  • 40. A pink spot in thyrotoxicosis.
    Widelitz M; Feldman W
    Biol Psychiatry; 1971; 3(2):181-4. PubMed ID: 5089913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.